Investment Team
Co-Managing Partner and Co-Head Flagship
Judith Charpentier joined Astorg in 2009 and serves as Co-Managing Partner and Co-Head of the Flagship Fund. She sits on both the Investment and Executive Committees. In 2016, she founded Astorg’s Healthcare practice and has since built it into the firm’s largest investment area, with over €6.5 billion deployed. Under her leadership, Astorg has become a reference in the sector, with key investments including Clario, CordenPharma, Nexpring, Cytel, Echosens, and HRA Pharma - many of which she sourced and led.
Before joining Astorg, Judith worked in Investment Banking at Morgan Stanley in both Europe and the U.S. She is based in Paris and graduated from ESSEC.
Nexpring Health
Nexpring Health is a global leader in Assisted Reproductive Technology(ART), providing consumables and equipment for in-vitro fertilization(IVF) procedures to hospitals, clinics and IVF labs across 115+ countries.
Investment year: 2024
Healthcare In Portfolio
OPEN Health
OPEN Health is a global leading medical affairs and market access platform serving the pharma industry.
Investment year: 2022
Healthcare In Portfolio
CordenPharma
CordenPharma is a leading CDMO focused on fast-growing complex niche drug modalities with end to end capabilities from early stage development to commercial large-scale manufacturing.
Investment year: 2022
Healthcare In Portfolio
Cytel
Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.
Investment year: 2021
Healthcare In Portfolio
Demetra
Demetra is a world-leading player in the bone cement and biomaterials space, serving all the major players in the orthopaedic industry.
Investment year: 2021
Healthcare In Portfolio
Clario
Clario delivers leading endpoint technology solutions for clinical trials.
Investment year: 2020
Healthcare In Portfolio
Echosens
Echosens is a specialized diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases.
Investment year: 2018
Healthcare In Portfolio
HRA Pharma
HRA is an innovative OTC pharma company with leading positions in Europe and in the US.
Investment year: 2016
Healthcare Realised